Evaluation of Scar Quality after Treatment of Superficial Burns with Dressilk<sup>®</sup> and Suprathel<sup>®</sup>—In an Intraindividual Clinical Setting
Background: Various synthetic and biological wound dressings are available for the treatment of superficial burns, and standard care differs among hospitals. Nevertheless, the search for an ideal wound dressing offering a safe healing environment as well as optimal scar quality while being economica...
Main Authors: | Jennifer Lynn Schiefer, Janine Andreae, Paul Christian Fuchs, Rolf Lefering, Paul Immanuel Heidekrueger, Alexandra Schulz, Mahsa Bagheri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-05-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/11/10/2857 |
Similar Items
-
Comparison of Long-Term Skin Quality and Scar Formation in Partial-Thickness Burn Wounds Treated with Suprathel<sup>®</sup> and epicite<sup>hydro®</sup> Wound Dressings
by: Jennifer Lynn Schiefer, et al.
Published: (2022-10-01) -
Comparative Clinical Study of Suprathel<sup>®</sup> and Jelonet<sup>®</sup> Wound Dressings in Burn Wound Healing after Enzymatic Debridement
by: Wolfram Heitzmann, et al.
Published: (2023-09-01) -
Organomonophosphines in Pt(η<sup>3</sup>-X<sup>1</sup>X<sup>2</sup>X<sup>3</sup>)(PR<sub>3</sub>), (X = N<sup>1</sup>, N<sup>2</sup>, N<sup>3</sup>; S<sup>1</sup>, S<sup>2</sup>, S<sup>3</sup>; or Te<sup>1</sup>, Te<sup>2</sup>, Te<sup>3</sup>) Derivatives: Structural Aspects
by: Milan Melník, et al.
Published: (2023-06-01) -
Safety and Feasibility of the BYCROSS<sup>®</sup> Atherectomy Device for the Treatment of Femoropopliteal Arterial Obstructions: Single-Center Short-Term Outcomes
by: Goudje L. van Leeuwen, et al.
Published: (2024-03-01) -
Heterotridentate Organomonophosphines in Pt(κ<sup>3</sup>–X<sup>1</sup>P<sup>1</sup>X<sup>2</sup>)(Y) (X<sup>1,2</sup> = N<sup>1,2</sup> or S<sup>1,2</sup>), Pt(κ<sup>3</sup>–P<sup>1</sup>N<sup>1</sup>X<sup>1</sup>)(Y) (X<sup>1</sup> = O, C, S or Se) Pt(κ<sup>3</sup>–P<sup>1</sup>S<sup>1</sup>Cl<sup>1</sup>)(Cl) and Pt(κ<sup>3</sup>–P<sup>1</sup>Si<sup>1</sup>N<sup>1</sup>)(OL)—Structural Aspects
by: Milan Melník, et al.
Published: (2022-12-01)